Erica L. Mayer, Kathy Miller, Komal L. Jhaveri, Randy Yeh, Elizabeth Sakach, Vikas Prasad, Denis Vasconcelos Ferreira, Paul Herszdorfer, Lucy Gong, Joanne Li, Lisa Bodei, Gary A. Ulaner. "RYZ101 (
            <sup>225</sup>
            Ac-DOTATATE) in patients with estrogen receptor-positive, human epidermal growth factor receptor 2–negative, locally advanced and unresectable, or metastatic breast cancer progressing after prior therapy: The phase 1b/2 TRACY-1 study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps3184